Handelsavisen
prelaunch
Companies Energy TRP.BX
TR
TRP.BX Oil & Gas

Teraplast SA

$0,45
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
0,37 %
Op margin
1,4 %
ROE
-0,8 %
Net margin
-1,4 %
Debt / equity
1,10
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Teraplast SA is a construction supplies and fixtures company that generates revenue primarily through the production and sale of plastic construction materials and related products.

Business. Teraplast SA (TRP.BX) is a company operating in the Construction Supplies & Fixtures industry within the Consumer Cyclicals sector. The firm generates revenue through the sale of products related to construction supplies and fixtures. Specific details regarding operating segments, headquarters location, and primary stock exchange listings are not available in the provided data. Consequently, the company is described at the industry level without geographic or segment-specific breakdowns.

Classification99 %
SectorEnergy
Industry groupOil & Gas
Generated · model-assisted
Sell-side consensus
BUY2 analysts
1 buy1 hold0 sell
Avg 12m price target0,53

Analyst recommendations

2 analysts · consensus Buy
Buy1
Hold1
Sell0
12-month price target
0,53
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
2 analysts · indicative
Ownership
not yet wired
Profitability
-0,8 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning TRP.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy · THIS SECTOR+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to TRP.BX. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Teraplast SA (TRP.BX) is a company operating in the Construction Supplies & Fixtures industry within the Consumer Cyclicals sector. The firm generates revenue through the sale of products related to construction supplies and fixtures. Specific details regarding operating segments, headquarters location, and primary stock exchange listings are not available in the provided data. Consequently, the company is described at the industry level without geographic or segment-specific breakdowns.

    Classification99 %
    SectorEnergy
    Industry groupOil & Gas
    AI synthesis
    GENERATED

    Teraplast's capital structure is characterized by a debt-to-equity ratio of 1.1, indicating a moderate reliance on debt financing. The company's liquidity position is weak, with only RON 71,390 in cash and equivalents, which is significantly lower than its long-term debt of RON 338,391,550. The current ratio of 1.06 suggests that the company has just enough current assets to cover its current liabilities, but with little room for operational flexibility.

    Profitability metrics for Teraplast are underperforming relative to industry norms. The company reported a net loss of RON 2,526,240 and an operating income of RON 2,400,540, resulting in a return on equity of -0.82% and a return on assets of -0.29%. These figures indicate that the company is not generating sufficient returns to cover its cost of capital, which is a concern for investors.

    Geographically, Teraplast's revenue is concentrated in a single market, as no segment or geographic breakdown is provided in the available data. This lack of diversification increases the company's exposure to regional economic fluctuations and regulatory changes. The absence of detailed segment data also limits the ability to assess the performance of different product lines or geographic regions.

    The company's growth trajectory is mixed. While it reported a revenue of RON 176,840,860, the net loss and negative free cash flow of RON 7,966,840 suggest that the company is not generating enough cash to sustain operations without external financing. The capital expenditure of RON 17,399,380 indicates ongoing investment in the business, but the negative free cash flow raises concerns about the sustainability of these investments.

    Risk factors for Teraplast include a medium liquidity risk, as highlighted by the negative net cash position after subtracting total debt. The company's dilution risk is currently low, but the potential for future dilution exists if the company needs to raise additional capital to fund operations or expansion. The risk assessment also notes that the company's liquidity position is a key flag, which could impact its ability to meet short-term obligations.

    Recent events and disclosures indicate that the company is under analyst scrutiny, with a mean price target of RON 0.53 and a median price target of RON 0.52. The mean recommendation of 2.50 suggests a neutral stance from analysts, with no strong buy recommendations and only one buy and one hold recommendation. These signals indicate that the market is cautious about the company's future performance and potential for growth.

    Key takeaways
    • Teraplast has a weak liquidity position with a current ratio of 1.06 and a negative net cash position.
    • The company is not generating sufficient returns, with a return on equity of -0.82% and a return on assets of -0.29%.
    • Teraplast's revenue is concentrated in a single market, increasing its exposure to regional economic and regulatory risks.
    • The company's growth is constrained by a net loss and negative free cash flow, despite ongoing capital expenditures.
    • Analysts have a neutral stance on Teraplast, with a mean price target of RON 0.53 and no strong buy recommendations.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 5

    Analysts project 17.1% upside to a mean price target of 0.5253, signaling potential undervaluation relative to current market price.

    Revenue demonstrated a 9.9% compound annual growth rate over the four-year period ending in fiscal year 2025.

    Gross profit expanded to 281.4 million RON in the latest fiscal year, indicating maintained top-line pricing power.

    Free cash flow improved significantly to -25.1 million RON in the latest year, showing reduced cash burn compared to prior periods.

    Dilution risk is assessed as low, suggesting existing shareholders face minimal immediate threat from equity issuance.

    BEAR CASE · 4

    The company carries high leverage with a debt-to-equity ratio of 2.9988, significantly exceeding the cohort median of 0.29.

    Credit risk is flagged as high, reflecting substantial concerns regarding the company's ability to meet its financial obligations.

    Operating margin of 1.36% falls below the cohort median of 4.64%, indicating inferior operational efficiency compared to peers.

    Return on equity is negative at -0.82%, placing the company in the bottom quartile of its construction supplies cohort.

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2026-02-26
    Q4 2025 · Quarter highlights

    Revenue RON 226.3M, +4,4% YoY; Operating income +116,9% YoY.

    RevenueRON 226.3M+4,4 % YoY
    Operating incomeRON 1.8M+116,9 % YoY
    Net income-RON 5.1M+59,4 % YoY
    Free cash flowRON 3.1M+120,6 % YoY
    EPS
    Operating cash flow-RON 12.4M−141,7 % YoY
    Financials
    Income statement
    RevenueRON 226.3M
    Gross profitRON 73.3M
    Operating incomeRON 1.8M
    Net income-RON 5.1M
    Margins
    Gross margin32.4%
    Operating margin0.8%
    Net margin-2.2%
    FCF margin1.4%
    Balance sheet
    Total assetsRON 1.13B
    Total liabilitiesRON 723.4M
    Total equityRON 404.7M
    Cash & equivalentsRON 173.1k
    Long-term debtRON 404.0M
    Cash flow
    Operating cash flow-RON 12.4M
    CapEx-RON 62.6M
    Free cash flowRON 3.1M
    SBC
    P&L flow · revenue → net income
    Revenue RON 226.3MOperating costs RON 224.6MTax RON 6.8MNet income RON 5.1M
    Highlights
    • Revenue RON 226.3M, +4,4% YoY
    • Operating income +116,9% YoY
    • Net income +59,4% YoY
    • Free cash flow +120,6% YoY
    • Net margin -2.2%

    Valuation FY

    Market price
    $0,45
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $307.9M
    Net cash
    -$338.3M
    Current ratio
    1.1
    Debt / equity
    1.1
    ROA
    -0.3%
    ROE
    -0.8%
    Cash conversion
    -165.0%
    CapEx / revenue
    -9.8%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    0,01
    Predicted surprise
    +0,00
    Beat probability
    45 %
    Analysts
    2
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-07 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate0,01
    Revenueno estimateno estimate1,2B RON
    Operating incomeno estimateno estimate70,0M RON
    Full-year consensus mean (period as reported by source) · consensus in RON. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution2 analysts
    Strong buy0
    Buy1
    Hold1
    Sell0
    Strong sell0
    12-month price target$0,53 · Median $0,52
    Low $0,46High $0,60
    Operating income · consensus70,0M RON
    EPS surprise
    −93,8 %
    reported vs consensus · miss
    Revenue surprise
    −10,3 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$0,46
    Mean$0,53
    Median$0,52
    High$0,60
    Spot$0,45
    +17.1 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin1,4 %Below median
    Net Margin-1,4 %Bottom quartile
    ROE-0,8 %Below median
    Capex / Rev-9,8 %Below median
    D/E1,10Bottom quartile
    Cash Conv-1,65Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • Teraplast SA Market data — financials · 2026-05-29
    • Teraplast SA Market data — analyst estimates · 2026-05-29

    Ownership & reference

    Leadership

    • Alexandru StaneanChief Executive Officer, Executive Director

    Insider activity

    — missing data

    Short positioning

    23.1Mshares short-28.7% vs prior
    8.62days to cover
    62.4%short of daily vol
    84.5Kfails-to-deliver
    as of 2026-07-15 · short-interest report (free)
    Index membership
    S&P/TSX 60Canada

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    TRP.BXCanonical
    — · USD

    Intel & risk

    PredictorBeat prob45 %Surprise+0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    • Shares outstanding (annual): 1.04BSEC XBRL filing
    • Long-term debt (YoY) (2024-12-31 vs 2023-12-31): 40.0%Derived (calculated)
    • Long-term debt (annual): USD 2.8BSEC XBRL filing
    • Long-term debt (YoY) (2023-12-31 vs 2022-12-31): 25.0%Derived (calculated)
    • Long-term debt (annual): USD 2BSEC XBRL filing
    • Shares outstanding (annual): 1.02BSEC XBRL filing
    • Long-term debt (annual): USD 1.6BSEC XBRL filing
    • Shares outstanding (annual): 981MSEC XBRL filing
    • Shares outstanding (annual): 940MSEC XBRL filing
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-07-30 00:00 UTCTRANSCRIPTEarnings call — Q3 2026
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-06-25 03:10 UTCHOLDERInstitutional holding changed
    2026-06-25 03:10 UTCHOLDER1 institutional position change flagged (1 major)
    2026-06-21 02:57 UTCHOLDERInstitutional holding changed
    2026-06-21 02:57 UTCHOLDER1 institutional position change flagged (1 major)
    2026-02-26 15:46 UTCEARNINGSQuarterly results — Q4 2025 Revenue RON 226.3M · Net RON -5.1M
    2026-02-26 15:46 UTCEARNINGSAnnual results — FY 2026 Revenue RON 1.08B · Net RON 1.2M
    2024-02-12 06:30 UTCEARNINGSAnnual results — FY 2024 Revenue RON 672.3M · Net RON 1.1M
    2023-02-01 06:09 UTCEARNINGSAnnual results — FY 2023 Revenue RON 711.1M · Net RON 15.4M
    2022-02-07 16:01 UTCEARNINGSAnnual results — FY 2022 Revenue RON 615.1M · Net RON 231.5M
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage